The changing world of clinical trials 2003-2017: A view from the AspECT trial
The past two decades have seen dramatic changes in clinical trial conduct and methodology. From trial regulation to data analysis, the rapid rise of randomised control trials (RCTs) has introduced many new techniques. Some methods of designing and conducting RCTs have been widely adopted, whereas ot...
Autors principals: | Reilly, G, Love, S, Wise, A, Scudder, C, Jankowski, J, Attwood, S |
---|---|
Format: | Conference item |
Publicat: |
BioMed Central
2017
|
Ítems similars
-
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
per: Jankowski, J, et al.
Publicat: (2018) -
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
per: Jankowski, J, et al.
Publicat: (2018) -
Chemoprevention of esophageal cancer with esomeprazole and aspirin therapy: efficacy and safety in the phase III randomized factorial AspECT Trial
per: Jankowski, JJ, et al.
Publicat: (2018) -
Barrett's oesophagus patients attending hospital: Baseline clinical, patient history and quality of life data from BOSS and AspECT
per: Love, S, et al.
Publicat: (2016) -
Valuing the effect sizes hypothesized in phase 3 trials of targeted therapies in oncology
per: Reilly, G, et al.
Publicat: (2017)